Vaccination with multiple peptides derived from novel cancer‐testis antigens can induce specific T‐cell responses and clinical responses in advanced esophageal cancerKoji Kono, Hideki Fujii, Yusuke Nakamura et al.|Cancer Science|2009Cited by 136
Phase I Study of Multiple Epitope Peptide Vaccination in Patients With Recurrent or Persistent Cervical CancerKosei Hasegawa, Keiichi Fujiwara, Yuji Ikeda et al.|Journal of Immunotherapy|2018Cited by 30
Adenovirus‐mediated <i>p53AIP1</i> gene transfer as a new strategy for treatment of p53‐resistant tumorsKoji Yoshida, Hirofumi Arakawa, Morito Monden et al.|Cancer Science|2004Cited by 19
Identification of immunogenic LY6K long peptide encompassing both CD4<sup>+</sup>and CD8<sup>+</sup>T-cell epitopes and eliciting CD4<sup>+</sup>T-cell immunity in patients with malignant diseaseYusuke Tomita, Yasuharu Nishimura, Akira Yuno et al.|OncoImmunology|2014Cited by 17